Heterogeneity of Surrogate Outcome Measures Used in Critical Care Studies: A Systematic Review

Overview

Journal Clin Trials

Publisher Sage Publications

Date 2023 Mar 22

PMID 36946422

Authors

Rejina Verghis

Bronagh Blackwood

Cliona McDowell

Philip Toner

Daniel Hadfield

Anthony C Gordon

Mike Clarke

Daniel McAuley

Affiliations

Soon will be listed here.

Abstract

Background: The choice of outcome measure is a critical decision in the design of any clinical trial, but many Phase III clinical trials in critical care fail to detect a difference between the interventions being compared. This may be because the surrogate outcomes used to show beneficial effects in early phase trials (which informed the design of the subsequent Phase III trials) are not valid guides to the differences between the interventions for the main outcomes of the Phase III trials. We undertook a systematic review (1) to generate a list of outcome measures used in critical care trials, (2) to determine the variability in the outcome reporting in the respiratory subgroup and (3) to create a smaller list of potential early phase endpoints in the respiratory subgroup.

Methods: Data related to outcomes were extracted from studies published in the six top-ranked critical care journals between 2010 and 2020. Outcomes were classified into subcategories and categories. A subset of early phase endpoints relevant to the respiratory subgroup was selected for further investigation. The variability of the outcomes and the variability in reporting was investigated.

Results: A total of 6905 references were retrieved and a total of 294 separate outcomes were identified from 58 studies. The outcomes were then classified into 11 categories and 66 subcategories. A subset of 22 outcomes relevant for the respiratory group were identified as potential early phase outcomes. The summary statistics, time points and definitions show the outcomes are analysed and reported in different ways.

Conclusion: The outcome measures were defined, analysed and reported in a variety of ways. This creates difficulties for synthesising data in systematic reviews and planning definitive trials. This review once again highlights an urgent need for standardisation and validation of surrogate outcomes reported in critical care trials. Future work should aim to validate and develop a core outcome set for surrogate outcomes in critical care trials.

Citing Articles

Definitions of digital biomarkers: a systematic mapping of the biomedical literature.

Macias Alonso A, Hirt J, Woelfle T, Janiaud P, Hemkens L BMJ Health Care Inform. 2024; 31(1).

PMID: 38589213 PMC: 11015196. DOI: 10.1136/bmjhci-2023-100914.

References

Morris P, Promes J, Guntupalli K, Wright P, Arons M . A multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults. Crit Care. 2010; 14(3):R125. PMC: 2911773. DOI: 10.1186/cc9089. View

Zhu B, Li Z, Jiang L, Du B, Jiang Q, Wang M . Effect of a quality improvement program on weaning from mechanical ventilation: a cluster randomized trial. Intensive Care Med. 2015; 41(10):1781-90. DOI: 10.1007/s00134-015-3958-z. View

Contentin L, Ehrmann S, Giraudeau B . Heterogeneity in the definition of mechanical ventilation duration and ventilator-free days. Am J Respir Crit Care Med. 2014; 189(8):998-1002. DOI: 10.1164/rccm.201308-1499LE. View

Maggiore S, Richard J, Abroug F, Diehl J, Antonelli M, Sauder P . A multicenter, randomized trial of noninvasive ventilation with helium-oxygen mixture in exacerbations of chronic obstructive lung disease. Crit Care Med. 2009; 38(1):145-51. DOI: 10.1097/CCM.0b013e3181b78abe. View

Hajjar L, Zambolim C, Belletti A, Almeida J, Gordon A, Oliveira G . Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial. Crit Care Med. 2019; 47(12):1743-1750. DOI: 10.1097/CCM.0000000000004023. View

Craig T, Duffy M, Shyamsundar M, McDowell C, OKane C, Elborn J . A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study). Am J Respir Crit Care Med. 2010; 183(5):620-6. DOI: 10.1164/rccm.201003-0423OC. View

Mistraletti G, Umbrello M, Salini S, Cadringher P, Formenti P, Chiumello D . Enteral versus intravenous approach for the sedation of critically ill patients: a randomized and controlled trial. Crit Care. 2019; 23(1):3. PMC: 6323792. DOI: 10.1186/s13054-018-2280-x. View

Routsi C, Gerovasili V, Vasileiadis I, Karatzanos E, Pitsolis T, Tripodaki E . Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial. Crit Care. 2010; 14(2):R74. PMC: 2887197. DOI: 10.1186/cc8987. View

Torgersen C, Dunser M, Wenzel V, Jochberger S, Mayr V, Schmittinger C . Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial. Intensive Care Med. 2009; 36(1):57-65. DOI: 10.1007/s00134-009-1630-1. View

10.

Parienti J, Megarbane B, Fischer M, Lautrette A, Gazui N, Marin N . Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: a randomized controlled study. Crit Care Med. 2010; 38(4):1118-25. DOI: 10.1097/CCM.0b013e3181d454b3. View

11.

EPSTEIN A, BIGGER Jr J, Wyse D, ROMHILT D, Hallstrom A . Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in the entire population enrolled. J Am Coll Cardiol. 1991; 18(1):14-9. DOI: 10.1016/s0735-1097(10)80210-4. View

12.

Hadfield D, Rose L, Reid F, Cornelius V, Hart N, Finney C . Neurally adjusted ventilatory assist versus pressure support ventilation: a randomized controlled feasibility trial performed in patients at risk of prolonged mechanical ventilation. Crit Care. 2020; 24(1):220. PMC: 7224141. DOI: 10.1186/s13054-020-02923-5. View

13.

Kirakli C, Naz I, Ediboglu O, Tatar D, Budak A, Tellioglu E . A randomized controlled trial comparing the ventilation duration between adaptive support ventilation and pressure assist/control ventilation in medical patients in the ICU. Chest. 2015; 147(6):1503-1509. DOI: 10.1378/chest.14-2599. View

14.

. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001; 69(3):89-95. DOI: 10.1067/mcp.2001.113989. View

15.

Albert M, Williamson D, Muscedere J, Lauzier F, Rotstein C, Kanji S . Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebo controlled pilot trial (CANTREAT study). Intensive Care Med. 2014; 40(9):1313-22. DOI: 10.1007/s00134-014-3352-2. View

16.

Hellyer T, McAuley D, Walsh T, Anderson N, Morris A, Singh S . Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation. Lancet Respir Med. 2019; 8(2):182-191. PMC: 7599318. DOI: 10.1016/S2213-2600(19)30367-4. View

17.

Gattas D, Rajbhandari D, Bradford C, Buhr H, Lo S, Bellomo R . A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults. Crit Care Med. 2015; 43(8):1622-9. DOI: 10.1097/CCM.0000000000001004. View

18.

Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter J . Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med. 2009; 38(1):152-60. DOI: 10.1097/CCM.0b013e3181b78671. View

19.

Jabaudon M, Hamroun N, Roszyk L, Guerin R, Bazin J, Sapin V . Effects of a recruitment maneuver on plasma levels of soluble RAGE in patients with diffuse acute respiratory distress syndrome: a prospective randomized crossover study. Intensive Care Med. 2015; 41(5):846-55. DOI: 10.1007/s00134-015-3726-0. View

20.

Perez-Barcena J, Crespi C, Regueiro V, Marse P, Raurich J, Ibanez J . Lack of effect of glutamine administration to boost the innate immune system response in trauma patients in the intensive care unit. Crit Care. 2010; 14(6):R233. PMC: 3219991. DOI: 10.1186/cc9388. View